<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-UAJNPZ1M</identifier><date>2015</date><creator>Carlsson, Jörgen</creator><relation>documents/doc/U/URN_NBN_SI_doc-UAJNPZ1M_001.pdf</relation><relation>documents/doc/U/URN_NBN_SI_doc-UAJNPZ1M_001.txt</relation><format format_type="issue">1</format><format format_type="volume">49</format><format format_type="type">article</format><format format_type="extent">str. 50-58, IV</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">279638016</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-UAJNPZ1M</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">izražanje receptorjev</subject><subject language_type_id="slv">mehur</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">sečila</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">tumorji</subject><subject language_type_id="slv">zdravljenje</subject><title>EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides</title></Record>